Unknown

Dataset Information

0

CD169+ sinus macrophages in regional lymph nodes do not predict mismatch-repair status of patients with colorectal cancer.


ABSTRACT:

Aims

Mismatch-repair deficiency and microsatellite instability-high (dMMR/MSI-H) colorectal cancer (CRC) is treated with programmed death (PD)-1 antibody regardless of PD-ligand (L)1 expression in tumor cells. We previously found that abundant CD169+ macrophages in regional lymph node (RLN) sinuses and CD8+ tumor-infiltrating lymphocytes (TILs) positively correlated in CRC and were associated with a favorable prognosis. However, associations between dMMR/MSI-H CRC and CD8+ TILs or prognoses vary among studies. In this study, we attempted to compare the association between MMR status, CD169+ macrophages in RLNs, CD8+ TILs, PD-L1 scores, and prognoses in CRC.

Methods and results

We immunostained 83 surgically resected CRC tumors that we previously analyzed for MMR proteins, and identified 9 that were dMMR. The number of CD169+ macrophages in RLNs and CD8+ TILs significantly correlated with overall survival, whereas MMR status did not. The number of cells positive for the TIL markers CD3, CD4, CD8, and TIA-1, and macrophage markers CD68 and CD169 in RLNs did not significantly differ between groups according to MMR status. Furthermore, combined positive scores (CPS) for PD-L1 expression in five of nine dMMR CRCs were all <1. We found that dMMR in CRC did not correlate with numbers of CD169+ macrophages in RLNs or CD8+ TILs.

Conclusions

CRC with CD169+ macrophages in RLNs and abundant CD8+ TILs indicates a better prognosis and it should be immunologically classified as a different antitumor group from dMMR CRC.

SUBMITTER: Saito Y 

PROVIDER: S-EPMC10225197 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

CD169<sup>+</sup> sinus macrophages in regional lymph nodes do not predict mismatch-repair status of patients with colorectal cancer.

Saito Yoichi Y   Fujiwara Yukio Y   Miyamoto Yuji Y   Ohnishi Koji K   Nakashima Yuta Y   Tabata Yasuhiko Y   Baba Hideo H   Komohara Yoshihiro Y  

Cancer medicine 20230227 9


<h4>Aims</h4>Mismatch-repair deficiency and microsatellite instability-high (dMMR/MSI-H) colorectal cancer (CRC) is treated with programmed death (PD)-1 antibody regardless of PD-ligand (L)1 expression in tumor cells. We previously found that abundant CD169<sup>+</sup> macrophages in regional lymph node (RLN) sinuses and CD8<sup>+</sup> tumor-infiltrating lymphocytes (TILs) positively correlated in CRC and were associated with a favorable prognosis. However, associations between dMMR/MSI-H CRC a  ...[more]

Similar Datasets

| S-EPMC5980134 | biostudies-literature
| S-EPMC7657174 | biostudies-literature
| S-EPMC4968600 | biostudies-literature
| S-EPMC11382037 | biostudies-literature
| S-EPMC2923071 | biostudies-literature
| S-EPMC10348701 | biostudies-literature
| S-EPMC5798840 | biostudies-literature
| S-EPMC9716256 | biostudies-literature
| S-EPMC5006907 | biostudies-other
| S-EPMC9015193 | biostudies-literature